GPC-5 mRNA was more abundant in primary prostate epithelial cells than the cancer cells, and these levels tended to decrease in the more metastatic prostate cancer cell lines such as DU-145 and PC-3 cells, as compared to a less metastatic cell line (LNCaP). This evidence concerns the gene GPC5 and prostate carcinoma.